Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Total Liabilities (2016 - 2025)

Historic Total Liabilities for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $158.9 million.

  • AtriCure's Total Liabilities rose 592.35% to $158.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $158.9 million, marking a year-over-year increase of 592.35%. This contributed to the annual value of $148.4 million for FY2024, which is 40.27% up from last year.
  • According to the latest figures from Q3 2025, AtriCure's Total Liabilities is $158.9 million, which was up 592.35% from $144.4 million recorded in Q2 2025.
  • In the past 5 years, AtriCure's Total Liabilities registered a high of $316.0 million during Q2 2021, and its lowest value of $122.2 million during Q1 2022.
  • Moreover, its 5-year median value for Total Liabilities was $135.3 million (2024), whereas its average is $155.2 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first tumbled by 6042.3% in 2022, then surged by 1481.81% in 2023.
  • Quarter analysis of 5 years shows AtriCure's Total Liabilities stood at $131.6 million in 2021, then fell by 2.18% to $128.7 million in 2022, then grew by 14.82% to $147.8 million in 2023, then rose by 0.4% to $148.4 million in 2024, then grew by 7.13% to $158.9 million in 2025.
  • Its Total Liabilities stands at $158.9 million for Q3 2025, versus $144.4 million for Q2 2025 and $137.0 million for Q1 2025.